• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

T1D Exchange, DreaMed Diabetes partnered for insulin treatment plans

June 11, 2019 By Danielle Kirsh

t1dexchange-dreameddiabetesT1D Exchange and DreaMed Diabetes recently announced that it has entered a partnership to provide six clinics in its Quality Improvement Collaborative with DreaMed Advisor Pro to improve insulin treatment plans.

The Quality Improvement Collaborative (QIC) is a data platform of 30,000 people with learning collaborative in 11 diabetes centers in the U.S. that are treating people who have Type 1 diabetes. DreaMed Advisor Pro is an artificial intelligence-based decision support system that will help T1D Exchange’s systems determine high-risk patients and the best treatment plans for maintaining balanced glucose levels.

“This partnership represents a whole new path toward impacting health outcomes for people with T1D,” interim chief operating officer at T1D Exchange said in a press release. “DreaMed’s Advisor Pro software will enable the clinics in our Quality Improvement Collaborative to understand how AI can support diabetes treatment decisions and better manage insulin therapy. We are excited to have DreaMed as our partner.”

DreaMed Advisor Pro is a cloud-based platform that analyzes data from continuous glucose monitors, self-monitoring blood glucose meters and insulin pump data to determine the best insulin delivery recommendations. It uses an event-based learning process to use different factors like basal rate, carbohydrate ratio and a correction factor to recommend the best treatment option. The insulin dosage recommendations are sent directly to a monitoring clinician who can adjust the patient’s diabetes management devices.

“In today’s rapidly changing world, technology offers a critical path to accelerate meaningful change in the management of T1D,” said Eran Atlas, co-founder and CEO of DreaMed. “From the standardization of care to optimizing outcomes, we are honored by this opportunity. It’s a true partnership among the scientists, clinicians, patients and caregivers.”

“Artificial intelligence-based decision support can save persons with diabetes, physicians and other members of the diabetes care team time. This means that the person with diabetes has to spend less time thinking about how to optimize their diabetes management and that clinicians can spend more time talking face to face with individuals with diabetes, rather than sifting through data reports to extract insights,” said endocrinologist Mark Clements, a faculty member at the Children’s Mercy Kansas City Diabetes Center and a member of the T1D Exchange QIC.

Filed Under: Diabetes Tagged With: DreaMed Diabetes, t1dexchange

IN CASE YOU MISSED IT

  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes
  • Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7
  • Tandem, Abbott strike deal to pair insulin pumps with glucose-ketone monitor

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS